Invokana and similar SGLT2 class drugs used to treat Type 2 diabetes are being investigated for causing serious side effects including:
- Kidney Failure
- Diabetic Ketoacidosis
- Dehydration Requiring Hospitalization
- Heart Attack
- Stoke
- Death
SGLT2 class drugs:
- Invokana® (canaglifozin)
- Invokamet® (canaglifozin and metformin)
- Farxiga® (dapaglifozin)
- Xigduo XR® (dapagliflozin and metformin extended-release)
- Glyxambi® (empagliflozin and linagliptin)
To refer a case contact Shane or Rebecca Langston at Langston Lawyers, PLLC